Abstract

BackgroundMetabolite profiling of biofluids has an emergent role in exploring the contribution of host-microbiome interactions to the treatment response of immune-mediated arthritis.[1]ObjectivesAs part of the FLORA trial (exploring the impact...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial.
Jose Ivan Contreras‐Serrano ... Matthew R Lewis
ACR open rheumatology | VOL. 5
Jose Ivan Contreras‐Serrano, et. al.Jose Ivan Contreras‐Serrano ... Matthew R Lewis
22 Sep 2023
OP0010 EFFICACY AND SAFETY OF FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE PERIPHERAL PSORIATIC ARTHRITIS: A RANDOMISED SHAM-CONTROLLED TRIAL
M Skov Kragsnaes ... P Ahlquist
-
M Skov Kragsnaes, et. al.M Skov Kragsnaes ... P Ahlquist
19 May 2021
POS0422 METABOLOMIC FINGERPRINT TO DISCRIMINATE REMISSION FROM ACTIVE DISEASE AND HEALTHY CONTROLS IN PSORIATIC ARTHRITIS
A Cauli ... M M Angioni
Annals of the Rheumatic Diseases | VOL. 82
A Cauli, et. al.A Cauli ... M M Angioni
30 May 2023
Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial
Hans Christian Horn ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. 80
Hans Christian Horn, et. al.Hans Christian Horn ... Robin Christensen
29 Apr 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
Myrto Kostopoulou ... Antonis Fanouriakis
Annals of the Rheumatic Diseases | VOL. -
Myrto Kostopoulou, et. al.Myrto Kostopoulou ... Antonis Fanouriakis
22 May 2024
View more papers